| CTRI Number |
CTRI/2025/03/082419 [Registered on: 17/03/2025] Trial Registered Prospectively |
| Last Modified On: |
09/03/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
A Clinical trial to study the effect of Erandbeejadi vati in Rheumatoid Arhtritis(Amavata) |
|
Scientific Title of Study
|
A Single Arm Clinical Study To Evalute The Efficacy Of Erandbeejadi Vati In The Management of Amavata With Special Reference To Rheumatoid Arthritis. |
| Trial Acronym |
RA |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Anilkumar |
| Designation |
pg scholar |
| Affiliation |
Kunwar shekhar vijendra ayurved medical college and research centre gangoh |
| Address |
Department of kayachikitsa kunwar shekhar vijendra ayurved medical college and research centre, Adarsh institutional area babu vijendra marg gangoh.
Saharanpur UTTAR PRADESH 247341 India |
| Phone |
09406668409 |
| Fax |
|
| Email |
anilkumar011m@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Bandana dhall |
| Designation |
professor |
| Affiliation |
Kunwar shekhar vijendra ayurved medical college and research centre gangoh |
| Address |
Department of kayachikitsa kunwar shekhar vijendra ayurved medical college and research centre, Adarsh institutional area babu vijendra marg gangoh.
Saharanpur UTTAR PRADESH 247341 India |
| Phone |
9348061460 |
| Fax |
|
| Email |
bandanadhall1981@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Bandana dhall |
| Designation |
professor |
| Affiliation |
Kunwar shekhar vijendra ayurved medical college and research centre gangoh |
| Address |
Department of kayachikitsa kunwar shekhar vijendra ayurved medical college and research centre, Adarsh institutional area babu vijendra marg gangoh.
Saharanpur UTTAR PRADESH 247341 India |
| Phone |
9348061460 |
| Fax |
|
| Email |
bandanadhall1981@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of kayachikitsa Kunwar shekhar vijendra ayurved medical college and research centre,babu vijendra marg,Gangoh,distt-Saharanpur,pincode-247341 Uttar Pradesh,India |
|
|
Primary Sponsor
|
| Name |
self |
| Address |
Adarsh Institutional Area,Babu Vijendra marg Gangoh,Distt-Saharanpur,Pincode-247341(UP)India. |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anil kumar |
Department of kayachikitsa First floor K.S.V.A.Medical college And Research Centre |
Adarsh Institutional Area Babu Vijendra marg Gangoh Distt-Saharanpur,Pincode-247341(UP)India. Saharanpur UTTAR PRADESH |
09406668409
anilkumar011m@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| KSVAMC-IEC/SUIEC |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:M958||Other specified acquired deformities of musculoskeletal system. Ayurveda Condition: AMAVATAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Erandbeejadi vati, Reference: Yogratnakar 28/64, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -koshnajal), Additional Information: -The assessment of the patient was done at the interval of 15days 30 days 45 days and the followup was done two month after completion of treatment. |
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1-Subjects willing to sign the consent forms. 2-Subjects in the age group between 20-70 year. 3-Either sex. 4-New cases of RA. 5-Subjects having sandhishool,sandhishoth,sandhistsbdhata,sparshaasahatva and associated lakshnas of amavata. 6-Chronicity should be less than 3 year. |
|
| ExclusionCriteria |
| Details |
1-Subject on standard treatment. 2-Subjects in the age group of less than 20 years and more than70 year will not be included for the present study.
3-Subjects having major illness and prediagnosed of Hypertension,HIV,Diabetes mellitus,Rheumatic fever were excluded from the study. 4-Deformity like swan neck,Boutonniere,Hitchhiker. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reduction in sign and symptoms of Rheumatoid arthritis. |
45 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| 1-Cost effective treatment. 2-To observe if there any side effect. |
45 days |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
24/03/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
1-The volunteer will be informed about the study protocol. 2- Willing participant will be randomly selected as per computer generated table. 3- The clinical research format will be validated. 4-Single centre,open labelled,Randomized,Interventional study. 5-comparing the safety and efficacy of Erandbeejadi vati in amavata. 6-Subjects are selected randomly computerised method on the basis of inclusion criteria. 7-Drugs are given to subjects in parallel group of40 patients. |